Clorazepate dipotassium and Bricanyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clorazepate dipotassium (clorazepate dipotassium) and Bricanyl (terbutaline sulfate). Common drug interactions include stevens-johnson syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Clorazepate dipotassium and Bricanyl. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Clorazepate dipotassium?

Clorazepate dipotassium has active ingredients of clorazepate dipotassium. It is often used in stress and anxiety. eHealthMe is studying from 2,708 Clorazepate dipotassium users. Check the latest studies of Clorazepate dipotassium.

What is Bricanyl?

Bricanyl has active ingredients of terbutaline sulfate. It is often used in asthma. eHealthMe is studying from 6,020 Bricanyl users. Check the latest studies of Bricanyl.

On Jul, 08, 2026

20 people who take Clorazepate dipotassium and Bricanyl together, and have interactions are studied.

Clorazepate dipotassium and Bricanyl drug interactions.

What are the common drug interactions of Clorazepate Dipotassium and Bricanyl, by gender? *:

female:

n/a

male:

Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Multi-organ failure (multisystem organ failure)
Nausea (feeling of having an urge to vomit)
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Skin lesion

What are the common drug interactions of Clorazepate Dipotassium and Bricanyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Urticaria (rash of round, red welts on the skin that itch intensely)

60+:

Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Fatigue (feeling of tiredness)
Insomnia (sleeplessness)
Multi-organ failure (multisystem organ failure)
Nausea (feeling of having an urge to vomit)
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Skin lesion

What are the existing conditions these people have? *

Coronary Heart Disease (narrowing or blockage of the coronary arteries): 17 people, 85.00%
Sedation: 16 people, 80.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 16 people, 80.00%
Alcohol Withdrawal Syndrome: 15 people, 75.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 15 people, 75.00%
Osteoporosis (bones weak and more likely to break): 15 people, 75.00%
Dyspnea (difficult or laboured breathing): 15 people, 75.00%
Hypokalemia (low potassium): 15 people, 75.00%
High Blood Pressure: 14 people, 70.00%
Heart Disease: 11 people, 55.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clorazepate dipotassium and Bricanyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously